Login / Signup

Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.

Raman PuriManish BansalVimal MehtaP Barton DuellNathan D WongS S IyengarDinesh KalraDevaki R NairNavin C NandaJagat NarulaP DeedwaniaJamal YusufJamshed J DalalSadanand ShettyVinod M VijanRajeev AgarwalaSoumitra KumarKris VijayAziz KhanGurpreet Singh WanderP C ManoriaS K WangnooViswanathan MohanShashank R JoshiBalbir SinghPrafulla KerkarRajesh RajputD PrabhakarAbdul Hamid ZargarBanshi SabooRavi R KasliwalSaumitra RaySandeep BansalM U RabbaniShibba Takkar ChhabraSarat ChandraNeil BardoloiNarasaraju KavalipatiImmaneni SathyamurthyKunal MahajanAkshya PradhanN N KhannaRajesh KhadgawatPreeti GuptaMilan C ChagAshu GuptaA MurugnathanS N NarasinganSundeep UpadhyayaVinod MittalRashida Patanwala MelinkeriMadhur YadavM Raseed MubarakK K PareekPradeep Kumar DablaRashmi NandaJ C Mohan
Published in: Journal of clinical lipidology (2024)
This document presents the updated risk stratification and treatment algorithm and describes the rationale for each modification. The intent of these updated recommendations is to modernize management of dyslipidemia in Indian patients with the goal of reducing the epidemic of ASCVD among Indians in Asia and worldwide.
Keyphrases
  • risk assessment
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • machine learning
  • clinical trial
  • fatty acid
  • peritoneal dialysis
  • deep learning
  • heavy metals
  • clinical practice